PolyActiva has announced the next important milestone of our transformational growth – the appointment of seasoned biopharmaceutical executive, Jerry St. Peter, as CEO and Board Director of PolyActiva, following the successful close of our $40M AUD ($25M USD) Series C financing.
Skip to content
Unit 21, 45-47 Normanby Road,
PolyActiva Pty Ltd
Unit 21, 45-47 Normanby Road,
Notting Hill VIC 3168, Australia
© 2025 PolyActiva. All Rights Reserved. Caution: PolyActiva products are not for sale in the US